Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sotos syndrome and healthy control subjects

ABSTRACT: Sotos syndrome and healthy control subjects

PROVIDER: PRJNA790836 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17278700.fastq.gz	Fastqsanger.gz
	SRR17278701.fastq.gz	Fastqsanger.gz
	SRR17278702.fastq.gz	Fastqsanger.gz
	SRR17278703.fastq.gz	Fastqsanger.gz
	SRR17278704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 25

Similar Datasets

Whole blood RNA-Seq of individuals with Sotos syndrome and healthy control subjects

Project description:To understand how NSD1 inactivation deregulates transcription, and to explore how this transcriptional deregulation affect human development, we profiled transcription in Sotos syndrome patients and healthy control individuals.

2022-03-01 | GSE191274 | GEO

Whole blood RNA-Seq of individuals with Sotos syndrome and healthy control subjects

Project description:Whole blood RNA-Seq of individuals with Sotos syndrome and healthy control subjects

| PRJNA790828 | ENA

Whole blood DNA methylation arrays of individuals with Sotos syndrome and healthy control subjects

Project description:Whole blood DNA methylation arrays of individuals with Sotos syndrome and healthy control subjects

| PRJNA790839 | ENA

Expression data from Sotos syndrome patients and controls

Project description:Genome-wide expression studies were performed on dermal fibroblasts from Sotos syndrome patients with a confirmed NSD1 abnormality and compared with age-sex matched controls. We used microarrays to detect differentially expressed genes in Sotos syndrome patients and performed a global test with the aim to map NSD1 within a signaling transduction pathway. Dermal fibroblasts were obtained from nine Sotos syndrome patients and nine controls. Since NSD1 is a co-factor of the retinoic acid receptor, cultures were performed both in the presence and absence of retinoic acid.

2014-02-06 | E-GEOD-27200 | biostudies-arrayexpress

Expression data from Sotos syndrome patients and controls

2014-02-06 | GSE27200 | GEO

Sotos syndrome and healthy control subjects

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-03-01 | GSE191277 | GEO

Transcription profiling of human adult postmortem brain tissue from Down syndrome and healthy control subjects

Project description:Down syndrome (DS) is the result of trisomy chromosome 21 but the mechanisms by which the genotype leads to the characteristic disease phenotype are unclear. We performed a microarray study using human adult brain tissue (dorsolateral prefrontal cortex) from DS subjects and healthy controls to characterise for the first time the human adult Down syndrome brain Experiment Overall Design: RNA extracted from human postmortem brain tissue from adult subjects with Down syndrome and healthy controls was hybridised to Affymetrix HG-U133A GeneChips to identify differentially expressed genes in the disease state.

2009-04-23 | E-GEOD-5390 | biostudies-arrayexpress

Whole blood DNA methylation arrays of individuals with Sotos syndrome and healthy control subjects

Project description:To understand how NSD1 inactivation deregulates DNA methylation, and to explore how these abnormalities affect human development, we profiled DNA methylation in SS patients and healthy control individuals using the Illumina Infinium EPIC Beadchip array.

2022-03-01 | GSE191276 | GEO

Expression profiling of human adult postmortem brain tissue from Down syndrome and healthy control subjects

2007-07-27 | GSE5390 | GEO

Chromatin regulation of transcriptional enhancers and cell fate by the Sotos syndrome gene NSD1 [RRBS]

Project description:Nuclear-receptor-binding SET-domain protein 1 (NSD1), a methyltransferase that catalyzes H3K36me2, is essential for mammalian development and frequently dysregulated in diseases, including Sotos syndrome. Despite impacts of H3K36me2 on H3K27me3 and DNA methylation, a direct role of NSD1 in transcriptional regulation remains largely unknown. Here, we show that NSD1 and H3K36me2 are enriched at cis-regulatory elements, particularly enhancers. NSD1 enhancer association is conferred by a tandem quadruple PHD-PWWP module, which recognizes p300-catalyzed H3K18ac. By combining acute NSD1 depletion with time-resolved epigenomic and nascent transcriptomic analyses, we demonstrate that NSD1 promotes enhancer-dependent gene transcription by facilitating RNA polymerase II pause release. Notably, NSD1 can act as a transcriptional coactivator independent of its catalytic activity. Moreover, NSD1 enables activation of developmental transcriptional programs associated with Sotos syndrome pathophysiology and controls ESC multilineage differentiation. Collectively, we have identified NSD1 as an enhancer-acting transcriptional coactivator that contributes to cell fate transition and Sotos syndrome development.

2023-07-05 | GSE236028 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data